258 related articles for article (PubMed ID: 29420117)
1. Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells.
Thepmalee C; Panya A; Junking M; Chieochansin T; Yenchitsomanus PT
Hum Vaccin Immunother; 2018 Jun; 14(6):1423-1431. PubMed ID: 29420117
[TBL] [Abstract][Full Text] [Related]
2. Suppression of TGF-β and IL-10 receptors on self-differentiated dendritic cells by short-hairpin RNAs enhanced activation of effector T-cells against cholangiocarcinoma cells.
Thepmalee C; Panya A; Sujjitjoon J; Sawasdee N; Poungvarin N; Junking M; Yenchitsomanus PT
Hum Vaccin Immunother; 2020 Oct; 16(10):2318-2327. PubMed ID: 31976810
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells.
Panya A; Thepmalee C; Sawasdee N; Sujjitjoon J; Phanthaphol N; Junking M; Wongkham S; Yenchitsomanus PT
Cancer Immunol Immunother; 2018 Oct; 67(10):1579-1588. PubMed ID: 30056600
[TBL] [Abstract][Full Text] [Related]
4. The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity.
Ahn YH; Hong SO; Kim JH; Noh KH; Song KH; Lee YH; Jeon JH; Kim DW; Seo JH; Kim TW
Clin Exp Immunol; 2015 Jul; 181(1):164-78. PubMed ID: 25753156
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
6. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
7. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells.
Gilliet M; Liu YJ
J Exp Med; 2002 Mar; 195(6):695-704. PubMed ID: 11901196
[TBL] [Abstract][Full Text] [Related]
8. Marina crystal minerals (MCM) activate human dendritic cells to induce CD4+ and CD8+ T cell responses in vitro.
Ghoneum MH; Ogura T; Gimzewski JK; Ghoneum AD; Henary MC; Agrawal S
Int J Immunopathol Pharmacol; 2018; 32():2058738418797768. PubMed ID: 30270704
[TBL] [Abstract][Full Text] [Related]
9. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
10. Late dendritic cells are still able to evoke a potent alloreactive CTL response.
Repnik U; Bergant M; Wraber B; Jeras M
Immunobiology; 2008; 213(1):51-64. PubMed ID: 18207027
[TBL] [Abstract][Full Text] [Related]
11. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPI.
Torres-Aguilar H; Blank M; Kivity S; Misgav M; Luboshitz J; Pierangeli SS; Shoenfeld Y
Ann Rheum Dis; 2012 Jan; 71(1):120-8. PubMed ID: 21914629
[TBL] [Abstract][Full Text] [Related]
12. STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells.
Okada S; Han S; Patel ES; Yang LJ; Chang LJ
Immunol Cell Biol; 2015; 93(5):461-71. PubMed ID: 25582338
[TBL] [Abstract][Full Text] [Related]
13. [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].
Li H; Ren XB; Zhang P; An XM; Liu H; Hao XS
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(44):3134-8. PubMed ID: 16405818
[TBL] [Abstract][Full Text] [Related]
14. Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.
Van Acker HH; Beretta O; Anguille S; De Caluwé L; Papagna A; Van den Bergh JM; Willemen Y; Goossens H; Berneman ZN; Van Tendeloo VF; Smits EL; Foti M; Lion E
Oncotarget; 2017 Feb; 8(8):13652-13665. PubMed ID: 28099143
[TBL] [Abstract][Full Text] [Related]
15. Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency.
Kim JH; Kang TH; Noh KH; Bae HC; Ahn YH; Lee YH; Choi EY; Chun KH; Lee SJ; Kim TW
Clin Exp Immunol; 2011 Aug; 165(2):180-9. PubMed ID: 21592111
[TBL] [Abstract][Full Text] [Related]
16. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells.
Carbonneil C; Saidi H; Donkova-Petrini V; Weiss L
Int Immunol; 2004 Jul; 16(7):1037-52. PubMed ID: 15184347
[TBL] [Abstract][Full Text] [Related]
18. Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: implications for dendritic cell immunization against cancer.
Lin CM; Wang FH; Lee PK
Clin Immunol; 2002 Jan; 102(1):96-105. PubMed ID: 11781072
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
20. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
Yang AS; Lattime EC
Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
